Latest filing published 23 Sept 2020 for Dyne Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -25.6%Entry US$22.06 · Close at T+365 US$16.42
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
VV Manager II, LLC: trading record in brief
VV Manager II, LLC discloses dealings in Dyne Therapeutics, Inc. to SEC (Form 4). The record holds 4 filings, all for trades on 21 September 2020.
The open-market record is one-sided, with 2 purchases worth €13.2M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 23 September 2020, reports a transaction in Dyne Therapeutics, Inc. The last insider purchase was made public on 23 September 2020, 2,238 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to VV Manager II, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 57,916 sharesCommon StockSEC:0000899243-20-026193:2
- 792,995 shares@ US$19.0097.3% of flowCommon StockSEC:0000899243-20-026193:1Canonical exit: 20 Dec 2020 (T+90)
- 22,005 shares@ US$19.002.7% of flowCommon StockSEC:0000899243-20-026193:3Canonical exit: 20 Dec 2020 (T+90)
- 2,087,130 sharesCommon StockSEC:0000899243-20-026193:0
4 of 4 declarations
